<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Genomics and pharmacogenomics in anticancer drug development and clinical response</title>
  </titleInfo>
  <name type="personal">
    <namePart>Innocenti, Federico.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nju</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Totowa, NJ</placeTerm>
    </place>
    <publisher>Humana</publisher>
    <dateIssued>2010</dateIssued>
    <dateIssued encoding="marc">2008</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xiv, 379p. :</extent>
  </physicalDescription>
  <tableOfContents>Genomic experimental approaches in oncology -- Pharmacogenomics of toxicity and response of chemotherapy -- Pharmacogenomics in clinical drug development in oncology.</tableOfContents>
  <note type="statement of responsibility">edited by Federico Innocenti.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Cancer</topic>
    <topic>Genetic aspects</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Cancer</topic>
    <topic>Molecular aspects</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Genomics</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Pharmacogenomics</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drug development</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Antineoplastic agents</topic>
    <topic>Development</topic>
  </subject>
  <subject authority="mesh">
    <topic>Antineoplastic Agents</topic>
  </subject>
  <subject authority="mesh">
    <topic>Genomics</topic>
  </subject>
  <subject authority="mesh">
    <topic>Neoplasms</topic>
    <topic>drug therapy</topic>
  </subject>
  <subject authority="mesh">
    <topic>Neoplasms</topic>
    <topic>genetics</topic>
  </subject>
  <subject authority="mesh">
    <topic>Pharmacogenetics</topic>
    <topic>methods</topic>
  </subject>
  <classification authority="lcc">RC271 .G46 2010</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>Cancer drug discovery and development</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn">1617376948</identifier>
  <identifier type="lccn" invalid="yes">2008938265</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">NLM</recordContentSource>
    <recordCreationDate encoding="marc">080925</recordCreationDate>
    <recordChangeDate encoding="iso8601">20230220110912.0</recordChangeDate>
    <recordIdentifier source="OSt">15472966</recordIdentifier>
  </recordInfo>
</mods>
